Rocket Lab (RKLB) Stock Price Prediction: Record backlog and analyst upgrades keep the rebound in focus

What changed

Rocket Lab (RKLB) is trading like a stock re-rating story, not a tired aerospace name waiting for a catalyst. The latest move followed the company’s November 9 third-quarter 2026 update, which said Rocket Lab posted record revenue, $1.2 billion of backlog, positive GAAP operating cash flow, and guided for record revenue and gross margin expansion in Q4 2026. TipRanks cited the post-earnings move as part of a four-day, 44% gain into November 11, 2026, while Yahoo Finance showed RKLB at $67.20 during market hours on November 11 before the stock later closed at $66.15. citeturn0search0

That matters because the market is not just responding to headline growth. It is rewarding proof that the current business is still scaling while investors wait for Neutron. TipRanks said Q3 revenue rose 73% year over year to $267.8 million, backlog jumped 52% to $3.57 billion, and Rocket Lab secured $515 million in new Neutron launch contracts despite the rocket’s inaugural flight slipping to 2027. citeturn0search0

Analyst tone is leaning constructive

Yahoo Finance listed an average analyst price target of $98.25 on November 11, with Cantor Fitzgerald’s latest rating shown as Overweight and Needham maintaining Buy while lowering its target from 120 to 100. Stockanalysis.com separately showed 22 analysts polled by S&P Global with a consensus Buy rating and an average target of $96.5, with a low of $58 and high of $150. That spread signals a market still debating how fast the rerating can continue, but not one that is questioning the core investment case outright. citeturn0search1turn0search2

Berenberg also raised its target to $85 from $83 on November 12 while keeping a Buy rating, saying launch orders are running at about seven times last year’s pace and that Neutron is already sold into the 2030s at a 27% higher base price than current offerings. The firm also said the existing business earns roughly a 10% adjusted EBITDA margin excluding about $45 million per quarter spent on Neutron R&D. citeturn0search3

Technical setup: trend is constructive, but the stock is extended

The tape is supportive, but not clean enough to call this a low-risk breakout. RKLB’s current price of $65.16 sits above the 7-day SMA at $58.21, the 20-day SMA at $55.54, and the 50-day SMA at $61.25, which is a bullish recovery structure. The 12-day EMA at $57.71 is also above the 26-day EMA at $57.24, reinforcing the short-term trend. citeturn0search4

At the same time, momentum is stretched. The daily RSI at 62.67 is neutral-to-firm rather than overbought, but the stochastic reading at 87.01 shows price is pressing near the top of its recent range. Bollinger data put RKLB above the upper band at $64.29, with %B at 1.0507, which is consistent with a stock trading above the band rather than comfortably inside it. The note that the move is occurring on only 0.14x of five-day average volume argues for caution: it is a bounce, but not yet a conviction breakout backed by heavy participation. citeturn0search4

Levels that matter now

The market’s immediate test is whether RKLB can hold above the $65.40 pivot and clear $68.11 immediate resistance. If that happens on better volume, the next reference is $71.07 strong resistance. On the downside, $62.44 is the first clean support, followed by $59.73 strong support. The average true range of $4.72 shows this is still a name that can move fast in either direction, so intraday swings around those levels can be sharp. citeturn0search4

Derivatives positioning: supportive, but not a standalone signal

Binance perpetual futures data is mildly constructive. Funding is neutral at 0.0000%, open interest is 90,807.95 contracts, and open interest value is $6.40 million with a 1.12% daily increase. The 1-hour global long/short ratio shows 57.0% long versus 43.0% short, while top-trader accounts are more tilted long at 62.3% versus 37.7%. Taker flow also leaned to the buy side at 1.1564. That points to positive short-term positioning, but it does not by itself prove durable upside. citeturn0search4

Bottom line

RKLB has shifted from a speculative aerospace trade into a market that is paying up for backlog growth, improving cash generation, and evidence that Neutron-related demand is real. The bull case stays intact as long as the stock holds the low-to-mid $60s and eventually proves it can absorb resistance near $68 to $71 on stronger volume. If it fails there and slips back under $62.44, the market is likely to treat the recent surge as an overextended post-earnings reaction rather than the start of a cleaner trend leg.